2-(4-Bromo-2,6-dimethoxyphenyl)-1,3-dioxolane, 98%, 1g

(R)-3-((tert-Butoxycarbonyl)amino)-3-cyclohexylpropanoic acid, 100mg

(R)-N-(2-Amino-4,5,6,7-tetrahydro-benzothiazol-6-yl)-propionamide, 97.0%, 250mg

4,6-Dichloro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidine, 98%, 10g

2-(5-Chloro-2,4-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

5-(Trifluoromethyl)pyrazin-2-amine, 95.0%, 250mg

2-(2-Bromo-1,1,2,2-tetrafluoroethoxy)-1,1,1,2,3,3-hexafluoro-3-(pentafluoroethoxy)propane>98.0%(GC)1g

3-Cyano-3-phenylpropanoic acid, 97%, 250mg

2-{4-[(TERT-BUTYL)OXYCARBONYL]PIPERAZINYL}-2-(2-THIENYL)ACETIC ACID, 95.0%, 5g

4-Methoxy-3-(3-methoxypropoxy)benzaldehyde, 95.0%, 1g

7-Methoxyindoline-2,3-dione, 95.0%, 250mg

3,4-Diaminothiophene Dihydrochloride>98.0%(HPLC)1g

Methyl 4-amino-2-chlorobenzoate, 94.0%, 500g